XML 28 R5.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows used in operating activities    
Net (loss) income $ 13,521 $ 19,925
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 7,210 7,315
Bad debt provision 36,643 18,170
Deferred income taxes (3,485) 42
Share-based compensation expense 4,597 4,409
Amortization of premium on marketable securities 795 1,073
Unrealized gain on deferred compensation fund investments (5,388) (3,790)
Changes in other long-term liabilities (334) (249)
Net loss on disposals of property and equipment 405 387
Changes in operating assets and liabilities:    
Accounts and notes receivable (48,056) (59,585)
Inventories and supplies 623 1,188
Prepaid expenses and other assets (3,491) 7,824
Deferred compensation funding 157 262
Accounts payable and other accrued expenses (15,695) (9,337)
Accrued payroll, accrued and withheld payroll taxes 1,862 (461)
Income taxes payable (2,921) (4,859)
Accrued insurance claims (1,576) 5,104
Deferred compensation liability 5,419 3,695
Net cash used in operating activities (9,714) (8,887)
Cash flows used in investing activities:    
Disposals of property and equipment 150 85
Additions to property and equipment (3,510) (2,097)
Acquisition of equity method investment (2,750) 0
Purchases of marketable securities (37,880) 0
Sales of marketable securities 27,951 1,375
Net cash used in investing activities (16,039) (637)
Cash flows from financing activities:    
Purchases of treasury stock (3,000) (2,223)
Proceeds from short-term borrowings 5,000 15,000
Payments of statutory withholding on net issuance of restricted stock units (1,030) (870)
Net cash from financing activities 970 11,907
Net (decrease) increase in cash, cash equivalents and restricted cash equivalents (24,783) 2,383
Cash, cash equivalents and restricted cash equivalents at beginning of the period 54,330 26,279
Cash, cash equivalents and restricted cash equivalents at end of the period $ 29,547 $ 28,662